WILLIAM J FEBBO Insider Trading $OPRX OptimizeRx Corp
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for WILLIAM J FEBBO.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of WILLIAM J FEBBO. WILLIAM J FEBBO is Director in Merriman Holdings, Inc ($MERR) and Director in Modular Medical, Inc. ($BLKE) and CHIEF EXECUTIVE OFFICER in OptimizeRx Corp ($OPRX).
WILLIAM J FEBBO in OptimizeRx Corp
Industry: SERVICES-BUSINESS SERVICES, NEC [7389]
Position of WILLIAM J FEBBO: CHIEF EXECUTIVE OFFICER
Holdings: 273,278 shares
Current Value: $202,226
Latest Transaction: Mar 26 2021
$OPRX Market Capitalization: $22.85M
$OPRX Previous Close: $0.74
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of WILLIAM J FEBBO in OptimizeRx Corp
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, MERR, BLKE, OPRX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 26 2021 | OPRX | OptimizeRx Corp | FEBBO WILLIAM J | CHIEF EXECUTIVE OFF ... | Option Exercise | M | 3.21 | 394,739 | 1,267,112 | 0 | |
| Mar 26 2021 | OPRX | OptimizeRx Corp | FEBBO WILLIAM J | CHIEF EXECUTIVE OFF ... | Payment of Exercise | F | 47.44 | 26,710 | 1,267,122 | 561,307 | 588 K to 561.3 K (-4.54 %) |
| Mar 26 2021 | OPRX | OptimizeRx Corp | FEBBO WILLIAM J | CHIEF EXECUTIVE OFF ... | Buy | M | 3.21 | 394,739 | 1,267,112 | 588,017 | 193.3 K to 588 K (+204.23 %) |
| Mar 26 2021 | OPRX | OptimizeRx Corp | FEBBO WILLIAM J | CHIEF EXECUTIVE OFF ... | Sell | S | 46.10 | 80,000 | 3,688,000 | 193,278 | 273.3 K to 193.3 K (-29.27 %) |
| Mar 26 2021 | OPRX | OptimizeRx Corp | FEBBO WILLIAM J | CHIEF EXECUTIVE OFF ... | Sell | S | 50.50 | 20,000 | 1,010,000 | 273,278 | 293.3 K to 273.3 K (-6.82 %) |
| Jan 11 2021 | OPRX | OptimizeRx Corp | FEBBO WILLIAM J | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 0.00 | 28,883 | 0 | 28,883 | |
| Jul 02 2020 | OPRX | OptimizeRx Corp | FEBBO WILLIAM J | CHIEF EXECUTIVE OFF ... | Option Exercise | M | 0.00 | 21,187 | 0 | 42,372 | |
| Jul 02 2020 | OPRX | OptimizeRx Corp | FEBBO WILLIAM J | CHIEF EXECUTIVE OFF ... | Buy | M | 0.00 | 21,187 | 0 | 229,719 | 208.5 K to 229.7 K (+10.16 %) |
| Jun 26 2020 | OPRX | OptimizeRx Corp | FEBBO WILLIAM J | CHIEF EXECUTIVE OFF ... | Option Exercise | M | 3.21 | 45,261 | 145,288 | 394,739 | |
| Jun 26 2020 | OPRX | OptimizeRx Corp | FEBBO WILLIAM J | CHIEF EXECUTIVE OFF ... | Buy | M | 3.21 | 45,261 | 145,288 | 208,528 | 163.3 K to 208.5 K (+27.72 %) |
| Mar 13 2020 | OPRX | OptimizeRx Corp | FEBBO WILLIAM J | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 0.00 | 84,746 | 0 | 84,746 | |
| Mar 05 2020 | OPRX | OptimizeRx Corp | FEBBO WILLIAM J | CHIEF EXECUTIVE OFF ... | Option Exercise | M | 3.21 | 30,000 | 96,300 | 440,000 | |
| Mar 05 2020 | OPRX | OptimizeRx Corp | FEBBO WILLIAM J | CHIEF EXECUTIVE OFF ... | Buy | M | 3.21 | 30,000 | 96,300 | 163,267 | 133.3 K to 163.3 K (+22.51 %) |
| Dec 05 2019 | OPRX | OptimizeRx Corp | FEBBO WILLIAM J | CHIEF EXECUTIVE OFF ... | Option Exercise | M | 3.21 | 30,000 | 96,300 | 470,000 | |
| Dec 05 2019 | OPRX | OptimizeRx Corp | FEBBO WILLIAM J | CHIEF EXECUTIVE OFF ... | Buy | M | 3.21 | 30,000 | 96,300 | 133,267 | 103.3 K to 133.3 K (+29.05 %) |
| Nov 06 2019 | OPRX | OptimizeRx Corp | FEBBO WILLIAM J | CHIEF EXECUTIVE OFF ... | Buy | P | 9.50 | 5,000 | 47,500 | 103,267 | 98.3 K to 103.3 K (+5.09 %) |
| Mar 29 2019 | OPRX | OptimizeRx Corp | FEBBO WILLIAM J | CHIEF EXECUTIVE OFF ... | Option Exercise | C | 0.00 | 80,000 | 0 | 30,000 | |
| Mar 29 2019 | OPRX | OptimizeRx Corp | FEBBO WILLIAM J | CHIEF EXECUTIVE OFF ... | Grant | A | 0.00 | 80,000 | 0 | 98,267 | 18.3 K to 98.3 K (+437.95 %) |
| Feb 26 2019 | OPRX | OptimizeRx Corp | FEBBO WILLIAM J | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 0.00 | 30,000 | 0 | 110,000 | |
| Feb 26 2019 | OPRX | OptimizeRx Corp | FEBBO WILLIAM J | CHIEF EXECUTIVE OFF ... | Option Exercise | J | 1.07 | 100,000 | 107,000 | 500,000 | |
| Dec 20 2018 | OPRX | OptimizeRx Corp | FEBBO WILLIAM J | CHIEF EXECUTIVE OFF ... | Buy | P | 9.94 | 2,000 | 19,880 | 18,267 | 16.3 K to 18.3 K (+12.29 %) |
| Nov 08 2018 | OPRX | OptimizeRx Corp | FEBBO WILLIAM J | CHIEF EXECUTIVE OFF ... | Buy | P | 16.32 | 600 | 9,792 | 16,267 | 15.7 K to 16.3 K (+3.83 %) |
| Jun 25 2018 | OPRX | OptimizeRx Corp | FEBBO WILLIAM J | CHIEF EXECUTIVE OFF ... | Buy | P | 10.50 | 1,000 | 10,500 | 15,667 | 14.7 K to 15.7 K (+6.82 %) |
| Feb 02 2018 | OPRX | OptimizeRx Corp | FEBBO WILLIAM J | Chief Executive Off ... | Option Exercise | A | 0.00 | 240,000 | 0 | 1,740,000 | |
| Dec 05 2016 | OPRX | OptimizeRx Corp | FEBBO WILLIAM J | Chief Executive Off ... | Buy | P | 0.85 | 4,000 | 3,400 | 44,000 | 40 K to 44 K (+10.00 %) |
| Nov 14 2016 | OPRX | OptimizeRx Corp | FEBBO WILLIAM J | CHIEF EXECUTIVE OFF ... | Buy | P | 0.90 | 9,000 | 8,100 | 40,000 | 31 K to 40 K (+29.03 %) |
| Jun 10 2016 | OPRX | OptimizeRx Corp | FEBBO WILLIAM J | CHIEF EXECUTIVE OFF ... | Buy | P | 1.10 | 11,567 | 12,724 | 31,000 | 19.4 K to 31 K (+59.52 %) |
| Jun 10 2016 | OPRX | OptimizeRx Corp | FEBBO WILLIAM J | CHIEF EXECUTIVE OFF ... | Buy | P | 1.06 | 10,000 | 10,600 | 19,433 | 9.4 K to 19.4 K (+106.01 %) |
Page: 1